Browsing Tag
Guardant Health Inc.
1 post
Guardant360 enters a new breast cancer workflow built on testing every three months
Guardant Health has secured FDA approval for Guardant360 CDx as the companion diagnostic for AstraZeneca’s Etcamah, introducing repeated liquid-biopsy testing during first-line metastatic breast cancer therapy.